Top Altcoins To Buy Now: 5 Revenue-Generating Tokens With Price Targets Up To $300

Most altcoins need a fresh story every week to stay relevant. An analyst has picked five that rely on something more durable like real fees that flow back into the token through buybacks, burns or staking rewards. He set two bullish price targets for each, running through 2028.

5. NEAR Protocol: targets of $30 and $60

NEAR is building tools that let users, and increasingly AI agents, swap across blockchains without using bridges. Its “intents” fee switch went live in February 2026, and part of that fee flow now counts as protocol revenue. The NEAR Foundation reported $20 billion in cumulative volume by July.

A $30 price would beat NEAR’s previous record of $20.44 and value the project at about $42 billion. The $60 target implies $84 billion. A proposal to cut token issuance to 1.6% is under discussion but has not been approved.

4. Injective: targets of $50 and $90

Injective trades near $7.50. The network is built for on-chain markets such as perpetuals and tokenized assets. Each month it uses revenue to buy back INJ and burn it permanently, and more than 7 million tokens have been destroyed so far.

The $50 target would take INJ back near its earlier high of $52.62. The upper target of $90 would put its market value at about $10 billion.

3. Aerodrome: targets of $3.50 and $6 to $8

Aerodrome, the main exchange on the Base network, trades near $0.80. Holders who lock their tokens can vote on which pools receive rewards and earn a share of exchange revenue. As of April 2026, it had recorded $185 billion in cumulative volume and $270 million in swap fees.

At $3.50, Aerodrome would be worth about $9.1 billion. The analyst added one caution: Aerodrome has announced a merger with Velodrome, and the final terms could change the token supply.

2. Pendle: targets of $8 and $15

Pendle trades near $2.40. The protocol lets users split a yield-bearing asset into two parts and trade the future yield separately. About 80% of its fees go toward buying back PENDLE, and stakers receive distributions every two weeks.

The $8 target sits just above its previous record of $7.50. The analyst said Pendle would need about $60 million in annual revenue to justify $8 and $100 million to justify $15.

1. Hyperliquid: targets of $200 and $300

Hyperliquid trades at about $89 to $90, close to its recent high near $97. It is already the largest business on the list, with about $685 million in revenue over the past year. Part of its fees are used to buy HYPE and burn it.

The targets imply a market value of $200 billion to $300 billion. To support that, the analyst said, Hyperliquid would need about $5 billion in annual revenue, more than seven times today’s level. He called that “an enormous hurdle.”

The analyst’s main point is that a bigger business does not always mean bigger upside. Hyperliquid has the scale, but smaller names such as Aerodrome and Injective would need less growth to deliver larger percentage gains.